In the GSE10072 array, we also observed that expression levels of AGR2 and CLDN3 are significantly upregulated in lung adenocarcinoma when compared to normal lung tissue (Figure 6A, 6B). This evidence concerns the gene AGR2 and lung adenocarcinoma.